Hr+/her2- metastatic breast cancer Clinical Trials

Delta Trials indexes 1 clinical trial for Hr+/her2- metastatic breast cancer in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 26 research sites around the world. An additional 1 trial are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.